Hls Identify Cta Issues Scenario 02

Skill: Clinical Trial Agreement Issue Identification — Scenario 02

1. Subject-matter triage

• Treat the CTA, side letter, and supporting materials as one integrated source set.
• Separate core agreement terms from ancillary documents, then test whether the ancillary papers create rights, duties, or operational workarounds that override the CTA.
• Identify whether the institution is the site, the sponsor-facing counterparty, or an operationally burdened third party, because the review standard turns on that role.
• If only one governing-law clause, one exclusion-screening regime, or one compensation structure is present, say so affirmatively before analyzing it; otherwise enumerate each variant and evaluate each separately.

2. Failure modes the skill is correcting

• A governing-law clause is accepted without checking whether it fits the institution’s home-state compliance structure and dispute posture.
• An exclusion-screening covenant is read as a one-time onboarding obligation when the text or playbook requires recurring review.
• Compensation tied to enrollment, procedures, or per-subject activity is not tested for fair-market-value support or compliance safeguards.
• A side letter or informal communication creates direct sponsor-to-investigator access that bypasses the institutional research office or equivalent oversight channel.
• Pass-through reimbursement language is treated as routine even though it leaves cost scope, cap, or prior-approval mechanics undefined.
• Protocol-deviation language fails to allocate regulatory response, corrective action, and reporting responsibilities with enough precision.
• Safety-reporting duties are not reconciled across sponsor, investigator, site, and institution documents, creating timing or recipient conflicts.

3. Legal frameworks / domain conventions that apply

• Governing law in CTAs: identify the chosen law and assess whether it is consistent with the institution’s location, compliance structure, and dispute-resolution implications for research operations.
• Exclusion screening: confirm whether the text requires screening only at onboarding or also on a recurring cadence; compare that obligation to applicable exclusion-screening guidance and local compliance practice.
• Compensation and fair market value: review whether subject-based compensation or site payments depend on volume, procedures, or enrollment milestones, and whether the agreement includes an FMV representation, certification, or validation process.
• Side-letter governance: check whether any ancillary document grants sponsor personnel direct operational access to the investigator or site outside the research office, and treat that as an oversight-risk issue.
• Pass-through costs: verify whether reimbursable direct costs are defined, capped, and subject to prior approval above a threshold; open-ended pass-through language is a cost-control issue.
• Protocol deviations: assess whether the agreement clearly allocates responsibility for deviation response, corrective action, escalation, and regulatory follow-up among sponsor and site personnel.
• Safety reporting: compare sponsor, investigator, and institutional reporting duties, recipients, and timelines across all documents to ensure the parallel pathways align.
• Use the controlling authority that actually supports the compliance point being made; do not state a conclusion without naming the governing rule, regulation, or recognized authority behind it.

4. Analytical scaffolds

1. Governing law

   • Identify the law selected in the CTA.
   • Compare it to the institution’s home jurisdiction and any forum or enforcement implications.
   • Flag any mismatch that could affect interpretation, oversight, or litigation posture.

2. Exclusion screening

   • Determine whether the agreement requires only initial screening or also recurring screening.
   • Compare the text to the applicable compliance standard and the institution’s practice.
   • State whether the cadence is complete, ambiguous, or under-specified.

3. Fair-market-value compensation

   • Determine whether compensation is tied to patient volume, procedures, enrollment, or other activity metrics.
   • Check for a documented FMV safeguard, certification, or review step.
   • Assess whether the payment structure creates an inducement, compliance, or audit-risk question.

4. Side letter bypass

   • Review all ancillary documents for direct operational rights, escalation channels, or contact provisions that route around the research office.
   • Determine whether the side letter changes the operational control structure or merely clarifies logistics.
   • Flag any bypass of institutional oversight as a governance issue.

5. Pass-through cost cap

   • Identify the reimbursement framework for direct costs and pass-through expenses.
   • Check for a defined cap, exclusions, and any prior-approval threshold.
   • Compare the text to the institutional playbook and note whether cost exposure is bounded.

6. Dual liability for deviations

   • Identify how the CTA allocates responsibility for protocol deviations, corrective action, and related regulatory response.
   • Test whether sponsor and site obligations are redundant, inconsistent, or incomplete.
   • State the operational, regulatory, or litigation consequence of any ambiguity.

7. Safety reporting alignment

   • Confirm that sponsor, investigator, site, and institutional reporting duties are consistent across the CTA, side letter, and incorporated materials.
   • Check timing, recipient, and content requirements for conflicts.
   • Flag any mismatch that could cause delayed reporting or duplicated reporting.

8. Issue closure

   • For each issue, identify the specific clause or omission.
   • Tie the issue to the governing authority or institutional standard.
   • State the practical consequence for the client and the recommended fix.

5. Vertical / structural / temporal relationships

• Read the CTA first, then test whether the side letter narrows, expands, or bypasses it.
• Treat incorporated exhibits, schedules, and support materials as controlling for operational details when the CTA points to them.
• If a later document conflicts with an earlier one, identify the conflict and specify which term should be harmonized.
• Distinguish between one-time obligations, ongoing obligations, and milestone-based obligations, because different compliance risks attach to each.
• Where multiple parties have parallel duties, map who acts first, who receives notice, and who bears escalation responsibility.

6. Output structure conventions

• Produce a prioritized issues memorandum, not a summary of the deal.
• Use an ordinal severity scale defined once at the top, and apply it uniformly to every issue.
• For each issue, include:
  • the clause or omission at issue;
  • the governing or compliance basis;
  • the severity level;
  • the client consequence;
  • the recommended revision or negotiation point.
• When a source document supplies a threshold, timing anchor, or numeric trigger, use it in the issue analysis; do not invent unsupported arithmetic.
• End with a concise Recommended Actions block that assigns each next step to a role and a timing anchor tied to the transaction or compliance workflow.
• Keep recommendations operational and specific; diagnoses without a fix are incomplete.
• Use conventional memorandum headings rather than the rubric’s internal section names.